These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2389450)

  • 1. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
    Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
    Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilot study on induction treatment with high-dose OKT3: preliminary observations in kidney transplantation.
    Welter HF; Illner WD; Schleibner S; Abendroth D; Hancke E; Groh J; Land W
    Transplant Proc; 1990 Oct; 22(5):2272. PubMed ID: 2120813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined immunosuppression (cyclosporin, azathioprine, methylprednisolone) in patients at immunological risk after kidney transplantation].
    Hillebrand G; Castro LA; Illner WD; Schleibner S; Land W; Gurland HJ
    Z Urol Nephrol; 1985 Dec; 78(12):667-71. PubMed ID: 3913221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
    Kirkman RL; Shapiro ME; Carpenter CB; McKay DB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1066-7. PubMed ID: 1989150
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
    Cortesini R; Berloco P; Famulari A; Trovati A; Iappelli M; Renna Molajoni E; Bachetoni A; Pretagostini R; Marinucci G; Capua A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
    [No Abstract]   [Full Text] [Related]  

  • 7. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M; Kirste G; Wanner U; Wilms H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 11. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants.
    Lloveras JJ; Tran Van T; Magues JP; Bernadet P; Durand D; Suc JM
    Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337
    [No Abstract]   [Full Text] [Related]  

  • 12. Monotherapy with cyclosporine in kidney transplantation.
    Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 14. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
    J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant low-dose cyclosporine and OKT3 therapy for renal transplant rejection.
    Hricik DE; Zarconi J; Schulak JA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1755-7. PubMed ID: 2652574
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal transplantation in children using cyclosporin A and azathioprine.
    Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of azathioprine, cyclosporine, and steroids on the graft and on cytologic patterns of rejection.
    Häyry P; von Willebrand E; Ahonen J; Eklund B; Salmela K; Höckerstedt K; Pettersson E; Koskimies S
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1650-1. PubMed ID: 3079031
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
    Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.